Last update 16 May 2026

BL-ARC002

Overview

Basic Info

Drug Type
Radiopharmaceuticals and diagnostic agent, Radionuclide Drug Conjugates (RDC)
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Neoplasms
Active Indication
Locally Advanced Malignant Solid NeoplasmLocally Advanced Malignant NeoplasmMetastatic Solid Tumor
Inactive Indication-
Originator Organization
Sichuan Biokin Pharmaceutical Co., Ltd.Sichuan Biokin Pharmaceutical Co., Ltd.
Active Organization
Sichuan Baili Pharmaceuticals Co.,LtdSichuan Baili Pharmaceuticals Co.,LtdSichuan Biokin Pharmaceutical Co., Ltd.Sichuan Biokin Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our ADC technology data.
login
or
view full example data
Boost your research with our ADC technology data.

Related

1
Clinical Trials associated with BL-ARC002
CTR20261802
/ Not yet recruitingPhase 1
评价 BL-ARC002 注射液在局部晚期或转移性实体瘤患者中的安全性、耐受性、药代动力学特征和初步疗效的 I 期临床研究
[Translation] A Phase I clinical study evaluating the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of BL-ARC002 injection in patients with locally advanced or metastatic solid tumors.
100 Clinical Results associated with BL-ARC002
Login to view more data
100 Translational Medicine associated with BL-ARC002
Login to view more data
100 Patents (Medical) associated with BL-ARC002
Login to view more data
100 Deals associated with BL-ARC002
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Locally Advanced Malignant Solid NeoplasmPhase 1
China
Sichuan Baili Pharmaceuticals Co.,LtdSichuan Baili Pharmaceuticals Co.,Ltd
01 May 2026
Locally Advanced Malignant NeoplasmIND Approval
China
Sichuan Biokin Pharmaceutical Co., Ltd.Sichuan Biokin Pharmaceutical Co., Ltd.
19 Mar 2026
Metastatic Solid TumorIND Approval
China
Sichuan Biokin Pharmaceutical Co., Ltd.Sichuan Biokin Pharmaceutical Co., Ltd.
19 Mar 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free